Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...

Russell Broadbent and a group comprising scientists, health professionals, lawyers, and academics, wrote to the Prime ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.